share_log

SenesTech | CORRESP: CORRESP

SenesTech | CORRESP: CORRESP

SenesTech | CORRESP：信函
美股SEC公告 ·  10/02 19:33

Moomoo AI 已提取核心信息

SenesTech, Inc., a biotechnology company based in Phoenix, Arizona, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3 to 4:00 p.m. Eastern time on October 4, 2024. The request, made in accordance with Rule 461 under the Securities Act of 1933, was submitted through a correspondence addressed to Jane Park at the SEC's Division of Corporation Finance, Office of Manufacturing. SenesTech has indicated that once the Registration Statement is declared effective, the company's counsel, Greenberg Traurig, LLP, should be orally notified. Thomas C. Chesterman, the Chief Financial Officer of SenesTech, signed the letter, acknowledging the company's understanding that the SEC's declaration does not preclude further action regarding the filing, nor does it absolve the company of its responsibility for the disclosure's adequacy and accuracy. The company also recognizes that it cannot use the SEC's declaration of effectiveness as a defense in any legal proceedings.
SenesTech, Inc., a biotechnology company based in Phoenix, Arizona, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3 to 4:00 p.m. Eastern time on October 4, 2024. The request, made in accordance with Rule 461 under the Securities Act of 1933, was submitted through a correspondence addressed to Jane Park at the SEC's Division of Corporation Finance, Office of Manufacturing. SenesTech has indicated that once the Registration Statement is declared effective, the company's counsel, Greenberg Traurig, LLP, should be orally notified. Thomas C. Chesterman, the Chief Financial Officer of SenesTech, signed the letter, acknowledging the company's understanding that the SEC's declaration does not preclude further action regarding the filing, nor does it absolve the company of its responsibility for the disclosure's adequacy and accuracy. The company also recognizes that it cannot use the SEC's declaration of effectiveness as a defense in any legal proceedings.
总部位于亚利桑那州凤凰城的生物技术公司senestech正式要求美国证券交易委员会（SEC）加快其S-3表格的注册声明生效日期至2024年10月4日美国东部时间下午4点。该请求是根据1933年证券法规461规定提交的，通过一封写给SEC公司融资司制造业办公室Jane Park的函件提出。senestech表示，一旦注册声明宣布生效，该公司的律师事务所Greenberg Traurig LLP应当口头通知。senestech的首席财务官Thomas C. Chesterman签署了这封信，承认公司理解SEC的声明并不排除对申报文件进一步操作，也不免除该公司对披露内容的充分性和准确性负责的责任。该公司还承认，不能将SEC的声明效力作为任何法律诉讼的辩护。
总部位于亚利桑那州凤凰城的生物技术公司senestech正式要求美国证券交易委员会（SEC）加快其S-3表格的注册声明生效日期至2024年10月4日美国东部时间下午4点。该请求是根据1933年证券法规461规定提交的，通过一封写给SEC公司融资司制造业办公室Jane Park的函件提出。senestech表示，一旦注册声明宣布生效，该公司的律师事务所Greenberg Traurig LLP应当口头通知。senestech的首席财务官Thomas C. Chesterman签署了这封信，承认公司理解SEC的声明并不排除对申报文件进一步操作，也不免除该公司对披露内容的充分性和准确性负责的责任。该公司还承认，不能将SEC的声明效力作为任何法律诉讼的辩护。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间